Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02235493 · ClinicalTrials.gov registry record
Non-interventional Substudy of ALX-HPP-502 to Assess Natural History of Patients With Juvenile-onset HPP Who Served as Historical Controls in ENB-006-09
A clinical trial, sponsored by Alexion Pharmaceuticals.
- Completed
- Registry status
- 6
- Enrollment target
NCT02235493 is a clinical trial that has completed, run by Alexion Pharmaceuticals. The registered enrollment target is 6 participants.
The verdict
NCT02235493 has completed, sponsored by Alexion Pharmaceuticals.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize the natural history of HPP in patients with Juvenile-onset HPP who served as historical controls in ENB-006-09.
Interventions
- BIOLOGICAL Retrospective Case Only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2014-08 |
| Est. Completion | 2014-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02235493
The ClinicalTrials.gov registry entry for NCT02235493 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alexion Pharmaceuticals, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Retrospective Case Only is the first listed.
NCT02235493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02235493 about?
NCT02235493 is a clinical study titled "Non-interventional Substudy of ALX-HPP-502 to Assess Natural History of Patients With Juvenile-onset HPP Who Served as Historical Controls in ENB-006-09". The purpose of this study is to characterize the natural history of HPP in patients with Juvenile-onset HPP who served as historical controls in ENB-006-09.
What is the current status of trial NCT02235493?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2014-08. Estimated completion is 2014-09.
What interventions are being tested in trial NCT02235493?
The interventions under investigation include: Retrospective Case Only (BIOLOGICAL).
Who is sponsoring clinical trial NCT02235493?
This trial is sponsored by Alexion Pharmaceuticals, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.